A new perspective on AD suggests that metabolic dysfunction, mitochondrial dysfunction, and oxidative stress have been identified as early contributors to AD, with amyloid and tau accumulation seen as later outcomes of wider metabolic and vascular disturbances [7]. This evidence concerns the gene MAPT and Alzheimer disease.